Stryker names Spencer Stiles as COO

Stiles has worked at Stryker for 27 years, most recently leading the company’s orthopedics business.

CHS sells lab assets to Labcorp for $194M

The deal, first announced in July, includes outreach laboratory services in 13 states. CHS will continue to operate inpatient and emergency department labs.

Olympus reinforces advice over device issue linked to 113 serious injuries

The company received complaints that the ligation loop can become unintentionally anchored in place.

Medtronic launches insulin delivery system with Abbott-made sensor

The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

Akura Medical raises $53M to advance thrombectomy portfolio

Part of the money will go toward setting up a joint venture in Qatar, whose sovereign wealth fund led the round.

PitchBook: AI tuck-in deals to drive M&A acceleration in 2026

Buyers will focus on “tuck-ins that add AI or data-driven capabilities or can meaningfully improve scale against emerging competitors,” the analysts said.

Medtronic names Jeb Denny as chief medical officer for acute care and monitoring

Denny leads the unit after Medtronic combined its patient monitoring and respiratory businesses last year.

Richard Pazdur, FDA drug czar, to retire from agency

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating what’s already been a turbulent year at the FDA.

Cleveland Diagnostics wins FDA nod for prostate cancer test

The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy procedure.

FDA flags risk from dropped BD Alaris pumps after 2 injury reports

BD told customers to immediately remove from use any devices they drop or severely jar.

Building a better robot: How Virtual Incision plans to challenge Intuitive

Led by former Intuitive executive Jim Alecxih, Virtual Incision expects the miniaturized design of its robot to stand out in an increasingly crowded field of challengers.